Brussels is considering emergency authorizations for “suitable” vaccines.
Arming Europe in the face of a pandemic that could drag on due to the proliferation of Covid-19 variants. This is the objective of the “biodefense” project presented Wednesday by Ursula von der Leyen with the Commissioners for Health and Industry, Stella Kyriakides and Thierry Breton. Called “Hera incubator”, it foreshadows what will be the future European agency dedicated to health emergencies – equivalent to the American Barda – which should be created in early 2023.
“The increased spread of new variants of Covid-19 – first identified in the UK, South Africa and Brazil – is a potential paradigm shift in the global fight against Covid-19”, warned the President of the Commission. So that the continent does not find itself overwhelmed by strains that would threaten the effectiveness of current and future vaccines, the watchword in Brussels is now to accelerate. And this, from one end of the chain, from the early detection of these variants
This article is for subscribers only. You have 76% left to discover.
Subscribe: 1 € the first month
Cancellable at any time
Already subscribed? Log in